Impax Laboratories (IPXL)

18.51 +0.08  +0.43%  May 21, 5:00PM
Add to Watchlists Create an Alert

Impax Laboratories Gross Profit TTM:

277.87M for March 31, 2013
View Full Chart

Impax Laboratories Gross Profit TTM Chart

    Impax Laboratories Historical Gross Profit TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 277.87M
    Dec. 31, 2012 282.55M
    Sept. 30, 2012 295.80M
    June 30, 2012 280.43M
    March 31, 2012 262.31M
    Dec. 31, 2011 258.30M
    Sept. 30, 2011 231.34M
    June 30, 2011 329.56M
    March 31, 2011 354.04M
    Dec. 31, 2010 539.26M
    Sept. 30, 2010 576.23M
    June 30, 2010 452.25M
    March 31, 2010 399.19M
    Dec. 31, 2009 188.10M
    Sept. 30, 2009 119.79M
    June 30, 2009 97.38M
    March 31, 2009 124.21M
    Dec. 31, 2008 118.10M
    Sept. 30, 2008
       
    June 30, 2008
    March 31, 2008 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Gross Profit (TTM)

    Definition: Gross Profit

    Learn More

    Get data for

    IPXL Gross Profit TTM Benchmarks

    Companies
    Mylan 2.936B
    Endo Health Solutions 1.863B
    Warner Chilcott 2.23B

    IPXL Gross Profit TTM Rankings

    Overall 78th percentile
    1694 of 8002
    Sector 79th percentile
    143 of 684 in Healthcare
    Industry 76th percentile
    16 of 68 in Drug Manufacturers - Specialty & Generic

    IPXL Gross Profit TTM Range, Past 5 Years

    Minimum 97.38M Jun 2009
    Maximum 576.23M Sep 2010
    Average 288.15M